102 related articles for article (PubMed ID: 21786248)
1. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Shen YM; Arbman G; Olsson B; Sun XF
Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucose transporter 1 (
Vasudevan S; Mehta A; Sharma SK; Sharma A
J Cancer Res Ther; 2022; 18(3):650-655. PubMed ID: 35900536
[TBL] [Abstract][Full Text] [Related]
3. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
5. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
6. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
Kuai XY; Lei ZY; Liu XS; Shao XY
Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
8. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.
Nakayama N; Yamashita K; Tanaka T; Kawamata H; Ooki A; Sato T; Nakamura T; Watanabe M
Clin Exp Metastasis; 2016 Jan; 33(1):3-13. PubMed ID: 26563151
[TBL] [Abstract][Full Text] [Related]
9. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
11. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Goos JA; de Cuba EM; Coupé VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-Van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
Ann Surg; 2016 Jan; 263(1):138-45. PubMed ID: 25563886
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Tohma T; Okazumi S; Makino H; Cho A; Mochizuki R; Shuto K; Kudo H; Matsubara K; Gunji H; Matsubara H; Ochiai T
Dis Esophagus; 2005; 18(3):185-9. PubMed ID: 16045581
[TBL] [Abstract][Full Text] [Related]
14. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Jun YJ; Jang SM; Han HL; Lee KH; Jang KS; Paik SS
World J Gastroenterol; 2011 Apr; 17(14):1866-73. PubMed ID: 21528061
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
